Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: J Mol Cell Cardiol. 2010 May 23;49(3):449–458. doi: 10.1016/j.yjmcc.2010.05.006

Table 3.

Mean±SEM of Diastolic and developed LV stiffness (n=6 per genotype)

Diastolic stiffness Developed stiffness
Treatment WT KO WT KO
Dobutamine 2.9±0.3 6.1±0.7## 7.0±0.4 10.1±1.2 #
Propranolol 3.2±0.3* 6.1±0.7# 4.0±0.4** 5.9±0.6**/ #

Stiffness: slope of wall stress (in mmHg) vs. LV volume (in µl) relation;

Asterisks: comparison between dobutamine and propranolol results using a paired t-test;

Number sign: comparison between WT and corresponding KO result using a t-test.